Expression of the tuberous sclerosis 2 gene product, tuberin, in adult and developing nervous system tissues

Neurobiology of Disease

Volumn 3, Issue 2, 1996, Pages 111-120

  Geist, Robert T ^a   Reddy, Anita J ^a   Zhang, Jie ^a   Gutmann, David H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN;

ANIMAL TISSUE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; IN SITU HYBRIDIZATION; MENTAL DEFICIENCY; MOUSE; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NEWBORN; NONHUMAN; OLFACTORY BULB; PRIORITY JOURNAL; PROTEIN FAMILY; SEIZURE; SPINAL CORD; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR GENE;

EID: 0030130431     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.1996.0011     Document Type: Article

References (19)

1. Basu, T. N., Gutmann, D. H., Fletcher, J. A., Glover, T. W., Collins, F. S., & Downward, J. (1992) Aberrant regulation of ras proteins in tumour cells from type 1 neurofibromatosis patients. Nature 356, 713-715.
2. European Chromosome 16 Tuberous Sclerosis Consortium. (1993) Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75, 1305-1315.
3. Geist, R. T., & Gutmann, D. H. (1995) The tuberous sclerosis 2 gene is expressed at high levels in the cerebellum and developing spinal cord. Cell Growth Differ. 6, 1477-1483.
4. Gomez, M. R. (1988) Tuberous Sclerosis, 2nd ed. Raven Press, New York.
5. Green, A. J., & Yates, J. R. W. (1993) Loss of heterozygosity on chromosome 16p in hamartomata from patients with tuberous sclerosis. Am. J. Hum. Genet. 53, 244.
6. Gutmann, D. H., Tennekoon, G. I., Cole, J. L., Collins, F. S., & Rutkowski, J. L. (1993) Modulation of the neurofibromatosis type 1 gene product, neurofibromin, during Schwann cell differentiation. J. Neurosci. Res. 36, 216-223.
7. Gutmann, D. H., Wood, D. L., & Collins, F. S. (1991) Identification of the neurofibromatosis type 1 gene product. Proc. Natl. Acad. Sci. USA 88, 9658-9662.
8. Haines, J. L., Short, M. P., Kwiatkowski, D. J., Jewell, A., Anderman, E., Bejjani, B., Yang, C. H., Gusella, J. F., & Amos, J. A. (1991) Localization of one gene for tuberous sclerosis within 9q32-34 and further evidence for heterogeneity. Am. J. Hum. Genet. 49, 764-772.
9. Hewett, S. J., Csernansky, C. A., & Choi, D. W. (1994) Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS. Neuron 13, 487-494.
10. Jansen, L. A. J., Pove, S., Atwood, J., Sandkuyl, L. A., Lindhout, D., Flodman, P., Smith, M., Sampson, J. R., Haines, J. L., Merkens, E. C., Fleury, P., Short, P., Amos, J., & Halley, D. J. J. (1991) A comparative study on genetic heterogeneity in tuberous sclerosis: evidence for one gene on 9q34 and a second on 11q22-23. Ann. N. Y. Acad. Sci. 615, 306-315.
11. Kobayashi, T., Hirayama, Y, Kobayashi, E., Kubo, E., & Hino, O. (1995a) A germline mutation in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer. Nature Genet. 9, 70-74.
12. Kobayashi, T., Nishizawa, M., Hirayama, Y., Kobayashi, E., & Hino, O. (1995b) cDNA structure, alternative splicing and exon-intron organization of the predisposing tuberous sclerosis (Tsc2) gene of the Eker rat model. Nucleic Acids Res. 23, 2608-2613.
13. Osborn, J. P., Fryer, A., & Webb, D. (1991) Epidemiology of tuberous sclerosis. Ann. N. Y. Acad. Sci. 615, 125-127.
14. Tsuchiya, H., Orimoto, K., Kobayashi, T., & Hino, O. (1996) Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model. Cancer Res. 56, 429-433.
15. Wienecke, R., Konig, A., & DeClue, J. E. (1995) Identification of tuberin, the tuberous sclerosis 2 product: tuberin possesses specific rap1GAP activity. J. Biol. Chem. 270, 16409-16414.
16. Xiao, G.-H., Jim, F., & Yeung, R. S. (1995) Identification of tuberous sclerosis 2 messenger RNA splice variants that are conserved and differentially expressed in rat and human tissues. Cell Growth Differ. 6, 1185-1191.
17. Xu, L., Sterner, C., Maheshwar, M. M., Wilson, P. J., Nellist, M., Short, P. M., Haines, J. L., Sampson, J. R., & Ramesh, V. (1995) Alternative splicing of the tuberous sclerosis (TSC2) gene in human and mouse tissues. Genomics 27, 475-480.
18. Yeung, R. S., Xiao, G.-H., Jin, F., Lee, W.-C., Testa, J. R., & Knudson, A. (1994) Predisposition to renal cell carcinoma in the Eker rat is determined by germline mutation of the tuberous sclerosis 2 (TSC2) gene. Proc. Natl. Acad. Sci. USA 91, 11413-11416.
19. Yoshida, Y., Kawata, M., Miura, Y., Musha, T., Sasaki, T., Kikuchi, A., & Takai, Y. (1992) Microinjection of smg/rap1/Krev-1 p21 into Swiss 3T3 cell induces DNA synthesis and morphological changes. Mol. Cell Biol. 12, 3407-3414.